4

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: October 15, 2024
Period of Report: January 30, 2024
Accession Number: 0001096906-24-002004

View Document ↗ View on SEC.gov ↗